Owlet (OWLT) Cash & Current Investments (2020 - 2026)
Owlet's (OWLT) quarterly Cash & Current Investments came in at $41.0 million in Q1 2026, up 6734.83% year-on-year from $600000.0 in Q1 2025, and little changed on a QoQ basis from $41.0 million in Q4 2025.
Owlet (OWLT) Cash & Current Investments (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Cash & Current Investments data on file, last reported at $41.0 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 6734.83% year-over-year to $41.0 million in Q1 2026; TTM through Mar 2026 was $41.0 million, a 6734.83% increase from a year earlier, with the FY2025 full-year figure at $41.0 million, up 95.13% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $41.0 million, roughly flat from $41.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for OWLT reached as high as $68.7 million in Q1 2022 and fell as low as $600000.0 in Q1 2025.
- Historically, Cash & Current Investments has averaged $25.1 million across 5 years, with a median of $22.1 million in 2025.
- Across the five-year window, Cash & Current Investments sank 96.74% in 2025 and soared 6734.83% in 2026, its largest moves.
- Year by year, Cash & Current Investments stood at $11.2 million in 2022, then jumped by 47.42% to $16.6 million in 2023, then increased by 26.94% to $21.0 million in 2024, then jumped by 95.13% to $41.0 million in 2025, then dropped by 0.0% to $41.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $41.0 million in Q1 2026, $41.0 million in Q4 2025, and $24.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Owlet | 143.93 Mn | 102.92 Mn | 12.24 Mn | 41.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.01 Mn |
| Dec 31, 2025 | 41.01 Mn |
| Sep 30, 2025 | 24.06 Mn |
| Jun 30, 2025 | 22.13 Mn |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 21.02 Mn |
| Sep 30, 2024 | 21.88 Mn |
| Jun 30, 2024 | 15.36 Mn |
| Mar 31, 2024 | 18.40 Mn |
| Dec 31, 2023 | 16.56 Mn |
| Sep 30, 2023 | 15.17 Mn |
| Jun 30, 2023 | 24.75 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 11.23 Mn |
| Sep 30, 2022 | 23.17 Mn |
| Jun 30, 2022 | 37.26 Mn |
| Mar 31, 2022 | 68.74 Mn |
| Dec 31, 2021 | 95.05 Mn |
| Sep 30, 2021 | 114.90 Mn |
| Mar 31, 2021 | 6.00 Mn |